Quest Partners LLC Sells 6,425 Shares of Balchem Co. (NASDAQ:BCPC)

Quest Partners LLC cut its holdings in shares of Balchem Co. (NASDAQ:BCPC) by 77.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,843 shares of the basic materials company’s stock after selling 6,425 shares during the quarter. Quest Partners LLC’s holdings in Balchem were worth $324,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the business. Envestnet Portfolio Solutions Inc. increased its holdings in shares of Balchem by 1.5% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 3,926 shares of the basic materials company’s stock worth $604,000 after purchasing an additional 59 shares during the period. Inspire Investing LLC increased its holdings in shares of Balchem by 2.7% during the third quarter. Inspire Investing LLC now owns 2,348 shares of the basic materials company’s stock worth $413,000 after purchasing an additional 62 shares during the period. Hsbc Holdings PLC increased its holdings in shares of Balchem by 1.5% during the second quarter. Hsbc Holdings PLC now owns 4,915 shares of the basic materials company’s stock worth $757,000 after purchasing an additional 75 shares during the period. Atomi Financial Group Inc. increased its holdings in shares of Balchem by 6.1% during the third quarter. Atomi Financial Group Inc. now owns 1,674 shares of the basic materials company’s stock worth $295,000 after purchasing an additional 96 shares during the period. Finally, Xponance Inc. increased its holdings in shares of Balchem by 5.2% during the second quarter. Xponance Inc. now owns 2,046 shares of the basic materials company’s stock worth $315,000 after purchasing an additional 102 shares during the period. 87.91% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. StockNews.com raised shares of Balchem from a “hold” rating to a “buy” rating in a research note on Monday, October 28th. HC Wainwright lifted their price objective on shares of Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a research note on Monday, November 4th.

Balchem Stock Performance

Shares of NASDAQ:BCPC opened at $182.69 on Tuesday. The company’s 50 day simple moving average is $173.84 and its 200 day simple moving average is $166.71. The stock has a market capitalization of $5.94 billion, a price-to-earnings ratio of 49.11, a price-to-earnings-growth ratio of 5.45 and a beta of 0.65. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.98 and a quick ratio of 1.90. Balchem Co. has a 1 year low of $120.87 and a 1 year high of $186.03.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.